KAT/3BP: A Metabolism-Targeting Agent with Single and Combination Activity in Aggressive B-Cell Lymphomas.
KAT/3BP：一种针对代谢的靶向药物，对侵袭性 B 细胞淋巴瘤具有单药和联合治疗活性
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17122034
Tarantelli Chiara, Spriano Filippo, Civanelli Elisa, Aresu Luca, Risi Giorgia, Cannas Eleonora, Kayali Omar, Cascione Luciano, Arribas Alberto J, Stathis Anastasios, Ko Young H, Bertoni Francesco
